Found: 23
Select item for more details and to access through your institution.
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1135815
- By:
- Publication type:
- Article
Inducible Epithelial Resistance against Coronavirus Pneumonia in Mice.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2020, v. 63, n. 4, p. 540, doi. 10.1165/rcmb.2020-0247LE
- By:
- Publication type:
- Article
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13473, doi. 10.1038/ncomms13473
- By:
- Publication type:
- Article
A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors*.
- Published in:
- ChemMedChem, 2021, v. 16, n. 6, p. 942, doi. 10.1002/cmdc.202000924
- By:
- Publication type:
- Article
Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.
- Published in:
- Mammalian Genome, 2024, v. 35, n. 2, p. 113, doi. 10.1007/s00335-024-10033-8
- By:
- Publication type:
- Article
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19055-7
- By:
- Publication type:
- Article
RIG-I Enhanced Interferon Independent Apoptosis upon Junin Virus Infection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0099610
- By:
- Publication type:
- Article
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0081587
- By:
- Publication type:
- Article
Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
- Published in:
- Pathogens, 2024, v. 13, n. 7, p. 539, doi. 10.3390/pathogens13070539
- By:
- Publication type:
- Article
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection.
- Published in:
- Scientific Reports, 2016, p. 31629, doi. 10.1038/srep31629
- By:
- Publication type:
- Article
Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 28, p. N.PAG, doi. 10.1002/adfm.201807616
- By:
- Publication type:
- Article
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 6, p. 1, doi. 10.1371/journal.ppat.1011777
- By:
- Publication type:
- Article
Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1185748
- By:
- Publication type:
- Article
Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 1, p. 166, doi. 10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L
- By:
- Publication type:
- Article
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 738, p. 1, doi. 10.1126/scitranslmed.adi0979
- By:
- Publication type:
- Article
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009897
- By:
- Publication type:
- Article
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00381-7
- By:
- Publication type:
- Article
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 1, p. 69, doi. 10.3390/v14010069
- By:
- Publication type:
- Article
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease.
- Published in:
- Journal of Infectious Diseases, 2019, v. 219, n. 5, p. 829, doi. 10.1093/infdis/jiy574
- By:
- Publication type:
- Article
Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article